Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe entities : Evotec se - adr save search
Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune cell engager platform
Published: 2023-12-11 (Crawled : 09:00) - biospace.com/
EVO | News | $7.19 -0.69% -0.7% 27K
|
Manufacturing
|
| O: 0.82%
H: 0.92%
C: 0.92%
cell agreement platform
Evotec SE Reports Results for the First Half-year 2023 and Provides Corporate Updates
Published: 2023-08-29 (Crawled : 07:00) - biospace.com/
EVO | News | $7.19 -0.69% -0.7% 27K
|
Manufacturing
|
| O: 0.97%
H: 5.5%
C: 5.5%
results
Just - Evotec Biologics Awarded Second Contract from U.S. Department of Defense Under Accelerated Antibodies Program
Published: 2023-07-05 (Crawled : 11:00) - biospace.com/
EVO | News | $7.19 -0.69% -0.7% 27K
|
Manufacturing
|
| O: 3.7%
H: 0.0%
C: -0.79%
defense contract program
Evotec Receives € 150 m Loan from European Investment Bank
Published: 2023-02-10 (Crawled : 11:00) - biospace.com/
EVO | News | $7.19 -0.69% -0.7% 27K
|
Manufacturing
|
| O: -0.1%
H: 0.3%
C: -1.31%
150
Evotec Announces Agreement with Janssen to Develop Immune-Based Therapies
Published: 2023-01-26 (Crawled : 09:00) - biospace.com/
EVO | News | $7.19 -0.69% -0.7% 27K
|
Manufacturing
|
| O: 7.07%
H: 1.17%
C: 0.39%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.02%
H: 0.21%
C: -0.39%
agreement
Evotec Adds Cell Therapy Manufacturing Facility with Acquisition of Rigenerand
Published: 2022-05-30 (Crawled : 09:00) - biospace.com/
EVOTF | News | $21.68 30.35% 3.2K
|
Health Technology
| Email alert
Add to watchlist
EVO | News | $7.19 -0.69% -0.7% 27K
|
Manufacturing
| Email alert
Add to watchlist
acquisition therapy
Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership in Protein Degradation
Published: 2022-05-10 (Crawled : 16:00) - biospace.com/
EVO | News | $7.19 -0.69% -0.7% 27K
|
Manufacturing
|
| O: 7.05%
H: 11.01%
C: 8.75%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.72%
H: 0.23%
C: -0.69%
partnership
Secarna Pharmaceuticals' Strategic Partner Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb
Published: 2022-04-12 (Crawled : 12:20) - biospace.com/
EVO | News | $7.19 -0.69% -0.7% 27K
|
Manufacturing
|
| O: -3.6%
H: 0.79%
C: -3.74%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -0.37%
H: 1.05%
C: 0.43%
collaboration designation
Evotec Presents Strategic Roadmap Towards Precision Medicine and Confirms Goals of Action Plan 2025 at Capital Markets Day
Published: 2022-03-02 (Crawled : 10:00) - biospace.com/
EVO | News | $7.19 -0.69% -0.7% 27K
|
Manufacturing
|
| O: 1.63%
H: 0.7%
C: 0.21%
day als
IMIDomics, Inc. Announces Strategic Investment from Drug Discovery and Research Leader Evotec SE
Published: 2022-02-15 (Crawled : 15:00) - biospace.com/
EVO | News | $7.19 -0.69% -0.7% 27K
|
Manufacturing
|
| O: 3.68%
H: 0.68%
C: 0.19%
drug research drug discovery
Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include New Targeted Protein Degradation Approach
Published: 2022-01-11 (Crawled : 11:00) - biospace.com/
EVO | News | $7.19 -0.69% -0.7% 27K
|
Manufacturing
|
| O: 5.87%
H: 0.0%
C: 0.0%
collaboration
EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership
Published: 2021-11-18 (Crawled : 12:30) - biospace.com/
EVO | News | $7.19 -0.69% -0.7% 27K
|
Manufacturing
|
| O: 4.43%
H: 2.27%
C: 1.05%
partnership drug discovery drug
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.